regulatory pathway for biosimilars
Published 6 years ago • 1.7K plays • Length 14:19Download video MP4
Download video MP3
Similar videos
-
4:05
the biosimilar regulatory pathway
-
1:44
fast facts about the regulatory approval pathway for biosimilars – amgen science
-
2:47
biosimilars: approval process
-
4:12
the basics of biosimilars
-
53:18
utilization of biosimilars: achieving value-based plan management
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
3:33
biosimilars: manufacturing and inherent variation
-
1:05:56
what’s next? biosimilars: the future of biosimilar drugs in the u.s.
-
16:47
what is needed and what is the role of biosimilars?
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
1:02:17
integrating insulin biosimilars into clinical practice: new pathways and new challenges
-
19:39
02 the us biosimilars regulatory pathway
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
5:20
data requirements for biosimilars
-
21:21
beyond reference biologics: biosimilars on the horizon
-
39:48
optimizing biosimilars for safe and effective management of imids
-
1:38:19
accelerating regulatory pathway for biologics & biosimilar drugs
-
2:04
biosimilars: the path to approval
-
4:20
the biosimilar development process
-
1:36
interchangeable biosimilars
-
3:40
biosimilars explained - hpra